Recurrence risk assessment for stage <scp>III</scp> colorectal cancer based on five methylation biomarkers in plasma cell‐free <scp>DNA</scp>-Reference-Cited by-同舟云学术

Recurrence risk assessment for stage III colorectal cancer based on five methylation biomarkers in plasma cell‐free DNA

Published:2023-01-28 Issue:4 Volume:259 Page:376-387
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:The Journal of Pathology

Author:

Wang Wei¹²,Zhu Xiaohui¹³,Zhang Xuecong⁴^ORCID,Lei Chengyong⁵,Zeng Zhicheng¹³,Lan Xiaoliang⁶,Cui Wenzhi²,Wang Feifei¹³,Xu Shaowan¹³,Zhou Juan⁷,Wu Xuehui¹³^ORCID,Deng Haijun⁶,Li Xia⁸,Fan Jianbing¹⁸,Ding Yanqing¹³,Huang Zhongxi⁹,Liang Li¹³^ORCID

Affiliation:

1. Department of Pathology, Nanfang Hospital and Basic Medical College Southern Medical University Guangzhou PR China

2. Department of Pathology, General Hospital of Southern Theater Command People's Liberation Army of China Guangzhou PR China

3. Guangdong Province Key Laboratory of Molecular Tumor Pathology Guangzhou PR China

4. Department of Bioinformatics, School of Basic Medicine Southern Medical University Guangzhou PR China

5. Department of Urology, Nanfang Hospital Southern Medical University Guangzhou PR China

6. Department of General Surgery, Nanfang Hospital Southern Medical University Guangzhou PR China

7. Department of Oncology, General Hospital of Southern Theater Command People's Liberation Army of China Guangzhou PR China

8. AnchorDx Medical Co., Ltd. Guangzhou PR China

9. Cancer Research Institute, School of Basic Medical Sciences Southern Medical University Guangzhou PR China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/path.6047

Reference51 articles.

1. Cancer statistics, 2020

2. Early Detection of Colorectal Cancer Recurrence in Patients Undergoing Surgery with Curative Intent: Current Status and Challenges

3. Metastasis Awakening: The challenges of targeting minimal residual cancer

4. Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer

5. Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genome‐wide and panel‐based cell‐free DNA characterization of patients with resectable esophageal adenocarcinoma;The Journal of Pathology;2023-08-24